An Observational follow-up study to Protocol 018

• Research type

  Research Study

• Full title

  An Observational Follow-Up Study for: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium (Protocol 018)

• IRAS ID

  144958

• Contact name

  Essam Eldin Hakim

• Contact email

  essam.hakim@synexus.com

• Eudract number

  2013-001526-26

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  14/LO/0046

• Date of REC Opinion

  14 Feb 2014

• REC opinion

  Further Information Favourable Opinion